Medistep HealthcareNSE:MEDISTEP +10.83%19 ROE % is 29.06% as of Mar. 2025, which is 47% below its 10-year median of 54.72. GuruFocus rates NSE:MEDISTEP with a GF Score™ of 19/100. The stock has 2 warning signs investors should review. Among 113 Medical Distribution companies, Medistep Healthcare ranks better than 92.92% on this metric.
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is one times the annual (Mar. 2025) net income data. The Revenue data used here is one times the annual (Mar. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Medistep Healthcare ROE % Related Terms
Medistep Healthcare ROE % Historical Data
* Premium members only.
The historical data trend for Medistep Healthcare's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medistep Healthcare ROE % Chart
Medistep Healthcare Annual Data
Trend
Mar22
Mar23
Mar24
Mar25
ROE %
57.29
131.24
52.14
29.06
Medistep Healthcare Semi-Annual Data
Mar22
Mar23
Mar24
Mar25
ROE %
57.29
131.24
52.14
29.06
NSE:MEDISTEP vs MCK, CAH, COR: ROE % Comparison
For the Medical Distribution subindustry, Medistep Healthcare's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medistep Healthcare ROE % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Medistep Healthcare's ROE % distribution charts can be found below:
* The bar in red indicates where Medistep Healthcare's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is one times the annual (Mar. 2025) net income data.
ROE % is displayed in the 30-year financial page.
Medistep Healthcare (NSE:MEDISTEP) has a ROE % of 29.06% as of Mar. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Medistep Healthcare and its competitors. This is 47% below median its historical median of 54.72. Over the past decade, Medistep Healthcare's ROE % has ranged from 29.06 to 131.24. According to the industry distribution chart, Medistep Healthcare ranks #8 out of 113 companies in the Medical Distribution industry, placing it in the top 7.1%.
Is Medistep Healthcare's ROE % too high?
Medistep Healthcare's current ROE % of 29.06% is 47% below median its 10-year median of 54.72. Over the past 10 years, this metric has ranged from a low of 29.06 to a high of 131.24. The Medical Distribution industry median ROE % is 7.10. Medistep Healthcare's value of 29.06% is 309.3% above this industry median. Based on the distribution chart, Medistep Healthcare ranks #8 out of 113 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Medistep Healthcare has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Medistep Healthcare's ROE % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Medistep Healthcare ranks #8 out of 113 companies for ROE %. This places Medistep Healthcare in the top 7% of its industry — outperforming the majority of peers. The industry median ROE % is 7.10. Medistep Healthcare's value of 29.06% is 309.3% above this benchmark. Historically, Medistep Healthcare's own ROE % has ranged from 29.06 to 131.24 over the past decade. While the company's 10-year median is 54.72 vs. the industry median of 7.10, Medistep Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Medical Distribution company?
The median ROE % among Medical Distribution companies is 7.10, based on 113 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medistep Healthcare's current ROE % of 29.06% is 309.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Medistep Healthcare and its competitors. For the Medical Distribution industry, the median ROE % is 7.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medistep Healthcare's current ROE % is 29.06%, which is 47% below median its own 10-year median of 54.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medistep Healthcare stock overvalued right now?
Medistep Healthcare (NSE:MEDISTEP) has a current ROE % of 29.06%. The current ROE % is 29.06%, which is 47% below median its 10-year median of 54.72 and 309.3% above the Medical Distribution industry median of 7.10. Medistep Healthcare's overall GF Score™ is 19/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Medistep Healthcare (NSE:MEDISTEP), the current ROE % is 29.06% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Medistep Healthcare Ltd operates in the pharmaceutical and healthcare product sectors. Its business includes manufacturing intimate care and hygiene products such as sanitary pads, as well as nutraceutical products like energy powders. The company also trades a variety of pharmaceutical, surgical, and medical equipment products. Medistep Healthcare's operations focus mainly on the western region of India, particularly in Gujarat. Its Core business activity is divided into the following categories: a) Trading of Pharmaceutical & Surgical products, b) Trading & Manufacturing of Nutraceuticals and Intimate care & hygiene products. The company generates the majority of its revenue from Trading and distribution.
19GF Score
Get the complete analysis for NSE:MEDISTEP
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MEDISTEP has been successfully added to your 